Skip to main content

Profile hero

Martin Hutchings

Partner

Capital markets | Corporate and acquisition financing | Leveraged finance | Private capital | Restructuring and capital solutions |

Martin is very calm and measured in his advice and also incredibly commercial and well-versed beyond his own specialist areas.

Chambers UK 2024

Profile details

About Martin Hutchings

Martin, whose practice encompasses all aspects of banking work, advises borrowers and lenders on complex multijurisdictional transactions, with an emphasis predominantly on corporate treasury transactions, including acquisition finance, IPO facilities, liquidity facilities and general corporate financings.

Martin's recent work has included numerous syndicated and bilateral corporate financings for clients such as Astrazeneca, Bakkavor, BT, Carnival Corporation, Compass Group, ConvaTec Group, Croda International, Currys, Daily Mail & General Trust, De La Rue, Flutter Entertainment, Grainger, Intercontinental Hotels Group, Japan Tobacco International, Kingfisher, London Stock Exchange Group, The Rank Group, RELX, Saga, SES, Spire Healthcare, SSP Group, Subsea 7 and Tesco.

Recent work

  • Advising Japan Tobacco International on its $4.3bn bridge facility to support its acquisition of Vector Group Ltd.
  • Advising Bakkavor on its syndicated term and revolving credit facilities.
  • Advising SES on its $3bn bridge facility to support its proposed acquisition of Intelsat and subsequent $1bn take-out term loan, together with its syndicated revolving credit facilities.
  • Advising Kingfisher on its syndicated working capital facilities, including ESG pricing adjustments.
  • Advising Keysight Technologies, Inc. on its £1.35bn bridge facility to support its proposed public acquisition of Spirent Communications plc.
  • Advising GXO Logistics, Inc on its £763m bridge facility to support its public acquisition of Wincanton plc.
  • Advising Mars, Inc on its bridge facility to support its public acquisition of Hotel Chocolat plc.
  • Advising The Rank Group in relation to its syndicated term and revolving credit facilities.
  • Advising ConvaTec Group on its $1.2bn syndicated term and revolving credit facilities.
  • Advising RELX on its $3bn syndicated working capital facilities including ESG pricing adjustments.
  • Advising Carnival Corporation on its syndicated revolving and bilateral facilities and forward start revolving credit facility.
  • Advising SSP Group on its syndicated term and revolving credit facilities.
  • Advising Compass Group on its syndicated and bilateral working capital facilities and LIBOR transition.
  • Advising London Stock Exchange Group on its c.$13.5bn bridge facilities to support its acquisition of Refinitiv Inc. and subsequent c.£4.5bn long term take-out facilities, together with other working capital revolving credit facilities.
  • Advising AstraZeneca plc on its $17.5bn bridge facilities to support its acquisition of Alexion Pharmaceuticals Inc. and subsequent $5bn long term take-out facilities together with other working capital bilateral credit facilities.
  • Advising Croda International on its term facility to support its acquisition of Avanti Polar Lipids, Inc., together with its syndicated working capital facilities (including ESG margin adjustment).
  • Advising GXO Logistics, Inc on its £745m bridge facility to support its public acquisition of Clipper Logistics plc.
  • Advising Berry Global Inc. on its acquisition facilities to support its public acquisition of RPC Group plc.
  • Advising Intercontinental Hotels Group plc on its syndicated and bilateral facilities, including its acquisition facilities to support its acquisition of Kimpton Hotels.
  • Advising Currys on its syndicated working capital facilities and Covid-19 liquidity facilities.
  • Advising Flutter Entertainment on its Term Loan A and revolving facilities, Term Loan B and Notes consent solicitation and intercreditor arrangements to support its acquisition of The Stars Group Inc.